Eclectic Associates’s AbbVie ABBV Stock Holding History

Eclectic Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.46M	Hold	5,575	–	–	0.16%	68
2026 Q2	$1.4M	Sell	5,575 -268	-5%	-$57.7K	0.16%	70
2026 Q1	$1.27M	Sell	5,843 -9	-0.2%	-$2K	0.17%	69
2025 Q4	$1.34M	Buy	5,852 +45	+0.8%	+$10.3K	0.21%	64
2025 Q3	$1.34M	Buy	5,807 +4	+0.1%	+$815	0.25%	60
2025 Q2	$1.08M	Hold	5,803	–	–	0.23%	64
2025 Q1	$1.22M	Hold	5,803	–	–	0.33%	60
2024 Q4	$1.03M	Buy	5,803 +4,756	+454%	+$874K	0.31%	63
2024 Q3	$207K	Buy	+1,047	New	+$195K	0.08%	99
2022 Q1	–	Sell	-1,872	Closed	-$253K	–	74
2021 Q4	$253K	Buy	+1,872	New	+$221K	0.16%	65

Other funds holding ABBV

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Eclectic Associates's ABBV Position: Q3 2026 in Review

Eclectic Associates held its AbbVie (ABBV) position steady in Q3 2026 at 5,575 shares worth $1.46M. The position accounts for 0.16% of the portfolio, ranked #68.

Eclectic Associates first reported a position in ABBV in Q4 2021 and has held it in 10 quarters since. 940 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Eclectic Associates held 5,575 shares of AbbVie worth $1.46M as of Q3 2026.
Eclectic Associates left its AbbVie share count unchanged in Q3 2026.
AbbVie made up 0.16% of Eclectic Associates's portfolio in Q3 2026, its #68 holding.
Eclectic Associates first reported a position in AbbVie in Q4 2021 and has held it in 10 quarters since.
940 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Eclectic Associates's 13F filing for Q3 2026, filed 9 Oct 2026.